Treatment Adherence And Follow Up Of MDR TB Patients’ in West Bengal
Treatment Adherence And Follow Up Of MDR TB Patients’ in West Bengal

Treatment Adherence And Follow Up Of MDR TB Patients’ in West Bengal

Treatment Adherence And Follow Up Of MDR TB Patients’ in West Bengal

The project aims to expand to contribute to the efforts to improve Multidrug- resistant tuberculosis (MDR-TB) patients’ outcomes through provision of personalized Multidrug- resistant tuberculosis (MDR-TB) patient education and counselling, follow up and support for treatment adherence and completion.

West Bengal

Highlights

  • Psychosocial counselling to patients at the DOTS Plus site and Tuberculosis Units (TU): Presently, five counsellors are providing counselling support to patients treated at the DR TB sites. Out of these five only one is providing the services at District TB Center (DTC), Howrah. The support is also extended to the patients and their family members through home visits and patient provider meetings.
  • Identify and train community DOT provider wherever needed with focus on counselling: The project has already sensitized 136 community based DOT providers in the previous phase. CARE India is training additional DOTS providers taking from tribal/dalit communities in MDR-TB treatment in close coordination with RNTCP The project will build capacity of 150 DOTS Plus providers during this extension period.
  • Organize Patient provider meetings: The project is continuing with this activity in the extension phase and is creating platform for the patients to discuss their problem with the Medical Officer, these meetings are generally conducted at the TU.
  • Advocacy & Sensitization meetings for Municipal Councillors, PRI members, local administration on DOTS plus: The PRIs are sensitized to DOTS and MDR-TB in order to enhance support available to patient and increase community awareness. The project is focussing on sensitizing 300 PRIs and 100 municipal councillors to involve them in the programme. This is done in close coordination with RNTCP. Around 170 PRI members and Municipal counsellors have already been sensitized in the current project.
  • Research and advocacy: CARE India is conducting study on the notification of TB cases from the private sector and the contribution of community pharmacists in this. Both the studies will help us to advocate at the national level for better interest of the program.
  • Involvement of community Pharmacists for referral of TB suspects and notification of TB cases: In this extension phase, more efforts is put on notification of TB patients under private sector and strengthen the reporting and recording of the pharmacists based on our experience of last phase.